Swiss Lions 100 | 2026 edition

Medacta

Medacta is No. 99 in the Swiss Lions 100 and No. 7 in Medtech & Lab Instruments, with a score of 31.7 out of 100. Headquarters: Castel San Pietro, canton of Ticino.

Swiss Lions score
31.7
Overall rank
99of 100

About

Orthopaedic medical device company in Castel San Pietro, canton of Ticino, making hip, knee, shoulder and spine implants.

How the score is made

Global scale

25

CHF 614m revenue.

Swiss value

60

Partly Swiss made.

Global visibility

4.7

Online attention across languages, and worldwide search interest.

Impact

0

No current SBTi target. Not a certified B Corp.

Philanthropy

20

Corporate foundation: Fondazione Medacta for Life.

Impact and philanthropy together make up the impact measure. How the ranking works.

Key figures

Revenue used in the ranking
CHF 614m12 months to June 2026, company
Revenue
EUR 708mTwelve months to 30 June 2026
Net profit
EUR 77mAttributable to shareholders
Dividends paid
EUR 24mTo all shareholders
Employees worldwide
2,273

Employees in Switzerland and dividends paid to Swiss shareholders are not published consistently, so they are not shown.

Profile

Headquarters
Castel San PietroCanton of Ticino
Language region
Italian-speaking
Ownership
Listed
Main customers
Businesses (B2B)
Chief executive
Francesco SiccardiSince 2018. Source
Founded
1999

Nearby in the Swiss Lions 100

Also in Medtech & Lab Instruments

See all 7 brands in Medtech & Lab Instruments.

Sources

  • Revenue used in the ranking: stockanalysis.com MOVE (12 months to June 2026).
  • Revenue, net profit, dividends and employees: stockanalysis.com, from company filings.
  • Climate target: Science Based Targets initiative dashboard, October 2026. Foundations: Swiss commercial register. B Corp: B Lab directory.

Something out of date?

If a figure is wrong, or Medacta can publish figures for the next edition, tell us. Corrections are recorded with their source.

Scroll to Top